243 related articles for article (PubMed ID: 22072872)
1. Rehydrated sterically stabilized phospholipid nanomicelles of budesonide for nebulization: physicochemical characterization and in vitro, in vivo evaluations.
Sahib MN; Darwis Y; Peh KK; Abdulameer SA; Tan YT
Int J Nanomedicine; 2011; 6():2351-66. PubMed ID: 22072872
[TBL] [Abstract][Full Text] [Related]
2. Solubilization of beclomethasone dipropionate in sterically stabilized phospholipid nanomicelles (SSMs): physicochemical and in vitro evaluations.
Sahib MN; Abdulameer SA; Darwis Y; Peh KK; Tan YT
Drug Des Devel Ther; 2012; 6():29-42. PubMed ID: 22393583
[TBL] [Abstract][Full Text] [Related]
3. Development of budesonide microparticles using spray-drying technology for pulmonary administration: design, characterization, in vitro evaluation, and in vivo efficacy study.
Naikwade SR; Bajaj AN; Gurav P; Gatne MM; Singh Soni P
AAPS PharmSciTech; 2009; 10(3):993-1012. PubMed ID: 19649711
[TBL] [Abstract][Full Text] [Related]
4. In vitro/in vivo investigation on the potential of Pluronic® mixed micelles for pulmonary drug delivery.
Pellosi DS; d'Angelo I; Maiolino S; Mitidieri E; d'Emmanuele di Villa Bianca R; Sorrentino R; Quaglia F; Ungaro F
Eur J Pharm Biopharm; 2018 Sep; 130():30-38. PubMed ID: 29890256
[TBL] [Abstract][Full Text] [Related]
5. Rehydrated lyophilized rifampicin-loaded mPEG-DSPE formulations for nebulization.
Abdulla JM; Tan YT; Darwis Y
AAPS PharmSciTech; 2010 Jun; 11(2):663-71. PubMed ID: 20405256
[TBL] [Abstract][Full Text] [Related]
6. Budesonide-hydroxypropyl-β-cyclodextrin inclusion complex in binary poloxamer 407/403 system for ulcerative colitis treatment: A physico-chemical study from micelles to hydrogels.
Santos Akkari AC; Ramos Campos EV; Keppler AF; Fraceto LF; de Paula E; Tófoli GR; de Araujo DR
Colloids Surf B Biointerfaces; 2016 Feb; 138():138-47. PubMed ID: 26674842
[TBL] [Abstract][Full Text] [Related]
7. Development of a Soluplus budesonide freeze-dried powder for nasal drug delivery.
Pozzoli M; Traini D; Young PM; Sukkar MB; Sonvico F
Drug Dev Ind Pharm; 2017 Sep; 43(9):1510-1518. PubMed ID: 28425305
[TBL] [Abstract][Full Text] [Related]
8. Ciclesonide and budesonide suspensions for nebulization delivery: An in vivo inhalation biopharmaceutics investigation.
Fu TT; Zhao Y; Yang FF; Wen H; Liu CY; Liao YH
Int J Pharm; 2018 Oct; 549(1-2):21-30. PubMed ID: 30048776
[TBL] [Abstract][Full Text] [Related]
9. Inhalable co-amorphous budesonide-arginine dry powders prepared by spray drying.
Lu W; Rades T; Rantanen J; Yang M
Int J Pharm; 2019 Jun; 565():1-8. PubMed ID: 30999050
[TBL] [Abstract][Full Text] [Related]
10. Design, physicochemical characterization, and optimization of organic solution advanced spray-dried inhalable dipalmitoylphosphatidylcholine (DPPC) and dipalmitoylphosphatidylethanolamine poly(ethylene glycol) (DPPE-PEG) microparticles and nanoparticles for targeted respiratory nanomedicine delivery as dry powder inhalation aerosols.
Meenach SA; Vogt FG; Anderson KW; Hilt JZ; McGarry RC; Mansour HM
Int J Nanomedicine; 2013; 8():275-93. PubMed ID: 23355776
[TBL] [Abstract][Full Text] [Related]
11. Pulmonary disposition of budesonide from liposomal dry powder inhaler.
Joshi M; Misra AN
Methods Find Exp Clin Pharmacol; 2001 Dec; 23(10):531-6. PubMed ID: 11957743
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel loaded PEG(5000)-DSPE micelles as pulmonary delivery platform: formulation characterization, tissue distribution, plasma pharmacokinetics, and toxicological evaluation.
Gill KK; Nazzal S; Kaddoumi A
Eur J Pharm Biopharm; 2011 Oct; 79(2):276-84. PubMed ID: 21575719
[TBL] [Abstract][Full Text] [Related]
13. Preparation and evaluation of βcyclodextrin-based nanosponges loaded with Budesonide for pulmonary delivery.
Salem YY; Hoti G; Sammour RMF; Caldera F; Cecone C; Matencio A; Shahiwala AF; Trotta F
Int J Pharm; 2023 Nov; 647():123529. PubMed ID: 37858636
[TBL] [Abstract][Full Text] [Related]
14. Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide.
Dufour G; Bigazzi W; Wong N; Boschini F; de Tullio P; Piel G; Cataldo D; Evrard B
Int J Pharm; 2015 Nov; 495(2):869-78. PubMed ID: 26410753
[TBL] [Abstract][Full Text] [Related]
15. Nanoporous CD-MOF particles with uniform and inhalable size for pulmonary delivery of budesonide.
Hu X; Wang C; Wang L; Liu Z; Wu L; Zhang G; Yu L; Ren X; York P; Sun L; Zhang J; Li H
Int J Pharm; 2019 Jun; 564():153-161. PubMed ID: 30981874
[TBL] [Abstract][Full Text] [Related]
16. PEGylated Liposomes of Meloxicam: Optimization by Quality by Design, in vitro Characterization and Cytotoxicity Evaluation.
Shaji J; Menon I
Pharm Nanotechnol; 2017; 5(2):119-137. PubMed ID: 28462699
[TBL] [Abstract][Full Text] [Related]
17. Ternary nanocomposite carriers based on organic clay-lipid vesicles as an effective colon-targeted drug delivery system: preparation and in vitro/in vivo characterization.
Kim HY; Cheon JH; Lee SH; Min JY; Back SY; Song JG; Kim DH; Lim SJ; Han HK
J Nanobiotechnology; 2020 Jan; 18(1):17. PubMed ID: 31964393
[TBL] [Abstract][Full Text] [Related]
18. Production, characterisation, and in vitro nebulisation performance of budesonide-loaded PLA nanoparticles.
Amini MA; Faramarzi MA; Gilani K; Moazeni E; Esmaeilzadeh-Gharehdaghi E; Amani A
J Microencapsul; 2014; 31(5):422-9. PubMed ID: 24697188
[TBL] [Abstract][Full Text] [Related]
19. Characterization of polymeric micelles for pulmonary delivery of beclomethasone dipropionate.
Gaber NN; Darwis Y; Peh KK; Tan YT
J Nanosci Nanotechnol; 2006; 6(9-10):3095-101. PubMed ID: 17048523
[TBL] [Abstract][Full Text] [Related]
20. Preparation of Budesonide-Loaded Liposomal Nanoparticles for Pulmonary Delivery and Their Therapeutic Effect in OVA-Induced Asthma in Mice.
Zuo X; Gu Y; Guo X; Zheng W; Zheng H; An Y; Xu C; Wang F
Int J Nanomedicine; 2024; 19():673-688. PubMed ID: 38283200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
